Orange Book product · Generic (ANDA)
PRAZOSIN HYDROCHLORIDE
PRAZOSIN HYDROCHLORIDE
At a glance
Dec 30, 2022
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 30, 2022
3 yr 6 mo ago
Today
Pharmaceutical detail
Active ingredient
PRAZOSIN HYDROCHLORIDE
Strength
EQ 1MG BASE
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 215697
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of PRAZOSIN HYDROCHLORIDE
- 1992MINIPRESS XLBrand (NDA)
NDA 019775 · PFIZER
- —MINIPRESSBrand (NDA)
NDA 017442 · PFIZER
- 2024PRAZOSIN HYDROCHLORIDEGeneric (ANDA)
ANDA 216727 · MSN
- 2024PRAZOSIN HYDROCHLORIDEGeneric (ANDA)
ANDA 214083 · LANNETT CO INC
- 2023PRAZOSIN HYDROCHLORIDEGeneric (ANDA)
ANDA 213052 · AUROBINDO PHARMA LTD
- 2023PRAZOSIN HYDROCHLORIDEGeneric (ANDA)
ANDA 217268 · ALEMBIC
- 2022PRAZOSIN HYDROCHLORIDEGeneric (ANDA)
ANDA 213406 · APPCO
- 2021PRAZOSIN HYDROCHLORIDEGeneric (ANDA)
ANDA 214608 · GRANULES
- 2018PRAZOSIN HYDROCHLORIDEGeneric (ANDA)
ANDA 210971 · NOVITIUM PHARMA
- 1989PRAZOSIN HYDROCHLORIDEGeneric (ANDA)
ANDA 072782 · AM THERAP
- 1989PRAZOSIN HYDROCHLORIDEGeneric (ANDA)
ANDA 072783 · AM THERAP
- 1989PRAZOSIN HYDROCHLORIDEGeneric (ANDA)
ANDA 072784 · AM THERAP
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
